Cargando…

Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study

PURPOSE: Tau pathology is associated with concurrent atrophy and decreased cerebral blood flow (CBF) in Alzheimer’s disease (AD), but less is known about their temporal relationships. Our aim was therefore to investigate the association of concurrent and longitudinal tau PET with longitudinal change...

Descripción completa

Detalles Bibliográficos
Autores principales: Visser, Denise, Verfaillie, Sander C. J., Bosch, Iris, Brouwer, Iman, Tuncel, Hayel, Coomans, Emma M., Rikken, Roos M., Mastenbroek, Sophie E., Golla, Sandeep S. V., Barkhof, Frederik, van de Giessen, Elsmarieke, van Berckel, Bart N. M., van der Flier, Wiesje M., Ossenkoppele, Rik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250461/
https://www.ncbi.nlm.nih.gov/pubmed/36976303
http://dx.doi.org/10.1007/s00259-023-06196-2
_version_ 1785055759130689536
author Visser, Denise
Verfaillie, Sander C. J.
Bosch, Iris
Brouwer, Iman
Tuncel, Hayel
Coomans, Emma M.
Rikken, Roos M.
Mastenbroek, Sophie E.
Golla, Sandeep S. V.
Barkhof, Frederik
van de Giessen, Elsmarieke
van Berckel, Bart N. M.
van der Flier, Wiesje M.
Ossenkoppele, Rik
author_facet Visser, Denise
Verfaillie, Sander C. J.
Bosch, Iris
Brouwer, Iman
Tuncel, Hayel
Coomans, Emma M.
Rikken, Roos M.
Mastenbroek, Sophie E.
Golla, Sandeep S. V.
Barkhof, Frederik
van de Giessen, Elsmarieke
van Berckel, Bart N. M.
van der Flier, Wiesje M.
Ossenkoppele, Rik
author_sort Visser, Denise
collection PubMed
description PURPOSE: Tau pathology is associated with concurrent atrophy and decreased cerebral blood flow (CBF) in Alzheimer’s disease (AD), but less is known about their temporal relationships. Our aim was therefore to investigate the association of concurrent and longitudinal tau PET with longitudinal changes in atrophy and relative CBF. METHODS: We included 61 individuals from the Amsterdam Dementia Cohort (mean age 65.1 ± 7.5 years, 44% female, 57% amyloid-β positive [Aβ +], 26 cognitively impaired [CI]) who underwent dynamic [(18)F]flortaucipir PET and structural MRI at baseline and 25 ± 5 months follow-up. In addition, we included 86 individuals (68 CI) who only underwent baseline dynamic [(18)F]flortaucipir PET and MRI scans to increase power in our statistical models. We obtained [(18)F]flortaucipir PET binding potential (BP(ND)) and R(1) values reflecting tau load and relative CBF, respectively, and computed cortical thickness from the structural MRI scans using FreeSurfer. We assessed the regional associations between i) baseline and ii) annual change in tau PET BP(ND) in Braak I, III/IV, and V/VI regions and cortical thickness or R(1) in cortical gray matter regions (spanning the whole brain) over time using linear mixed models with random intercepts adjusted for age, sex, time between baseline and follow-up assessments, and baseline BP(ND) in case of analyses with annual change as determinant. All analyses were performed in Aβ−  cognitively normal (CN) individuals and Aβ+  (CN and CI) individuals separately. RESULTS: In Aβ+ individuals, greater baseline Braak III/IV and V/VI tau PET binding was associated with faster cortical thinning in primarily frontotemporal regions. Annual changes in tau PET were not associated with cortical thinning over time in either Aβ+ or Aβ−  individuals. Baseline tau PET was not associated with longitudinal changes in relative CBF, but increases in Braak III/IV tau PET over time were associated with increases in parietal relative CBF over time in Aβ + individuals. CONCLUSION: We showed that higher tau load was related to accelerated cortical thinning, but not to decreases in relative CBF. Moreover, tau PET load at baseline was a stronger predictor of cortical thinning than change of tau PET signal. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06196-2.
format Online
Article
Text
id pubmed-10250461
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-102504612023-06-10 Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study Visser, Denise Verfaillie, Sander C. J. Bosch, Iris Brouwer, Iman Tuncel, Hayel Coomans, Emma M. Rikken, Roos M. Mastenbroek, Sophie E. Golla, Sandeep S. V. Barkhof, Frederik van de Giessen, Elsmarieke van Berckel, Bart N. M. van der Flier, Wiesje M. Ossenkoppele, Rik Eur J Nucl Med Mol Imaging Original Article PURPOSE: Tau pathology is associated with concurrent atrophy and decreased cerebral blood flow (CBF) in Alzheimer’s disease (AD), but less is known about their temporal relationships. Our aim was therefore to investigate the association of concurrent and longitudinal tau PET with longitudinal changes in atrophy and relative CBF. METHODS: We included 61 individuals from the Amsterdam Dementia Cohort (mean age 65.1 ± 7.5 years, 44% female, 57% amyloid-β positive [Aβ +], 26 cognitively impaired [CI]) who underwent dynamic [(18)F]flortaucipir PET and structural MRI at baseline and 25 ± 5 months follow-up. In addition, we included 86 individuals (68 CI) who only underwent baseline dynamic [(18)F]flortaucipir PET and MRI scans to increase power in our statistical models. We obtained [(18)F]flortaucipir PET binding potential (BP(ND)) and R(1) values reflecting tau load and relative CBF, respectively, and computed cortical thickness from the structural MRI scans using FreeSurfer. We assessed the regional associations between i) baseline and ii) annual change in tau PET BP(ND) in Braak I, III/IV, and V/VI regions and cortical thickness or R(1) in cortical gray matter regions (spanning the whole brain) over time using linear mixed models with random intercepts adjusted for age, sex, time between baseline and follow-up assessments, and baseline BP(ND) in case of analyses with annual change as determinant. All analyses were performed in Aβ−  cognitively normal (CN) individuals and Aβ+  (CN and CI) individuals separately. RESULTS: In Aβ+ individuals, greater baseline Braak III/IV and V/VI tau PET binding was associated with faster cortical thinning in primarily frontotemporal regions. Annual changes in tau PET were not associated with cortical thinning over time in either Aβ+ or Aβ−  individuals. Baseline tau PET was not associated with longitudinal changes in relative CBF, but increases in Braak III/IV tau PET over time were associated with increases in parietal relative CBF over time in Aβ + individuals. CONCLUSION: We showed that higher tau load was related to accelerated cortical thinning, but not to decreases in relative CBF. Moreover, tau PET load at baseline was a stronger predictor of cortical thinning than change of tau PET signal. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06196-2. Springer Berlin Heidelberg 2023-03-28 2023 /pmc/articles/PMC10250461/ /pubmed/36976303 http://dx.doi.org/10.1007/s00259-023-06196-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Visser, Denise
Verfaillie, Sander C. J.
Bosch, Iris
Brouwer, Iman
Tuncel, Hayel
Coomans, Emma M.
Rikken, Roos M.
Mastenbroek, Sophie E.
Golla, Sandeep S. V.
Barkhof, Frederik
van de Giessen, Elsmarieke
van Berckel, Bart N. M.
van der Flier, Wiesje M.
Ossenkoppele, Rik
Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study
title Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study
title_full Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study
title_fullStr Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study
title_full_unstemmed Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study
title_short Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study
title_sort tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250461/
https://www.ncbi.nlm.nih.gov/pubmed/36976303
http://dx.doi.org/10.1007/s00259-023-06196-2
work_keys_str_mv AT visserdenise taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT verfailliesandercj taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT boschiris taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT brouweriman taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT tuncelhayel taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT coomansemmam taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT rikkenroosm taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT mastenbroeksophiee taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT gollasandeepsv taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT barkhoffrederik taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT vandegiessenelsmarieke taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT vanberckelbartnm taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT vanderflierwiesjem taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy
AT ossenkoppelerik taupathologyasdeterminantofchangesinatrophyandcerebralbloodflowamultimodallongitudinalimagingstudy